Logo image of ARQ

ARQ INC (ARQ) Stock Fundamental Analysis

USA - NASDAQ:ARQ - US00770C1018 - Common Stock

7.16 USD
-0.24 (-3.24%)
Last: 9/26/2025, 8:00:00 PM
7.16 USD
0 (0%)
After Hours: 9/26/2025, 8:00:00 PM
Fundamental Rating

3

ARQ gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. ARQ has a bad profitability rating. Also its financial health evaluation is rather negative. ARQ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ARQ had negative earnings in the past year.
ARQ had a positive operating cash flow in the past year.
ARQ had negative earnings in 4 of the past 5 years.
In multiple years ARQ reported negative operating cash flow during the last 5 years.
ARQ Yearly Net Income VS EBIT VS OCF VS FCFARQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

ARQ's Return On Assets of -0.58% is on the low side compared to the rest of the industry. ARQ is outperformed by 60.24% of its industry peers.
The Return On Equity of ARQ (-0.76%) is comparable to the rest of the industry.
ARQ has a worse Return On Invested Capital (0.53%) than 79.52% of its industry peers.
Industry RankSector Rank
ROA -0.58%
ROE -0.76%
ROIC 0.53%
ROA(3y)-3.97%
ROA(5y)1.37%
ROE(3y)-5.19%
ROE(5y)0.32%
ROIC(3y)N/A
ROIC(5y)N/A
ARQ Yearly ROA, ROE, ROICARQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

1.3 Margins

ARQ has a Operating Margin of 1.47%. This is in the lower half of the industry: ARQ underperforms 75.90% of its industry peers.
ARQ's Gross Margin of 36.27% is fine compared to the rest of the industry. ARQ outperforms 75.90% of its industry peers.
In the last couple of years the Gross Margin of ARQ has grown nicely.
Industry RankSector Rank
OM 1.47%
PM (TTM) N/A
GM 36.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.52%
GM growth 5Y4.26%
ARQ Yearly Profit, Operating, Gross MarginsARQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ARQ is destroying value.
Compared to 1 year ago, ARQ has more shares outstanding
The number of shares outstanding for ARQ has been increased compared to 5 years ago.
Compared to 1 year ago, ARQ has an improved debt to assets ratio.
ARQ Yearly Shares OutstandingARQ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ARQ Yearly Total Debt VS Total AssetsARQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 3.48 indicates that ARQ is not in any danger for bankruptcy at the moment.
ARQ's Altman-Z score of 3.48 is fine compared to the rest of the industry. ARQ outperforms 78.31% of its industry peers.
ARQ has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.13, ARQ belongs to the best of the industry, outperforming 87.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 3.48
ROIC/WACC0.06
WACC9.1%
ARQ Yearly LT Debt VS Equity VS FCFARQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

2.3 Liquidity

ARQ has a Current Ratio of 1.10. This is a normal value and indicates that ARQ is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.10, ARQ is not doing good in the industry: 89.16% of the companies in the same industry are doing better.
A Quick Ratio of 0.65 indicates that ARQ may have some problems paying its short term obligations.
The Quick ratio of ARQ (0.65) is worse than 87.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.65
ARQ Yearly Current Assets VS Current LiabilitesARQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 91.67% over the past year.
Looking at the last year, ARQ shows a quite strong growth in Revenue. The Revenue has grown by 11.96% in the last year.
Measured over the past years, ARQ shows a quite strong growth in Revenue. The Revenue has been growing by 9.22% on average per year.
EPS 1Y (TTM)91.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y2.8%
Revenue growth 5Y9.22%
Sales Q2Q%12.51%

3.2 Future

Based on estimates for the next years, ARQ will show a very strong growth in Earnings Per Share. The EPS will grow by 63.64% on average per year.
ARQ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.79% yearly.
EPS Next Y95.41%
EPS Next 2Y109.09%
EPS Next 3Y88.93%
EPS Next 5Y63.64%
Revenue Next Year10.84%
Revenue Next 2Y16.73%
Revenue Next 3Y16.47%
Revenue Next 5Y17.79%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ARQ Yearly Revenue VS EstimatesARQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
ARQ Yearly EPS VS EstimatesARQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5 2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ARQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ARQ is valuated quite expensively with a Price/Forward Earnings ratio of 27.44.
Based on the Price/Forward Earnings ratio, ARQ is valued a bit more expensive than the industry average as 63.86% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of ARQ to the average of the S&P500 Index (23.05), we can say ARQ is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 27.44
ARQ Price Earnings VS Forward Price EarningsARQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ARQ is valued a bit more expensive than the industry average as 78.31% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.59
ARQ Per share dataARQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ARQ's earnings are expected to grow with 88.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y109.09%
EPS Next 3Y88.93%

More info and screens

0

5. Dividend

5.1 Amount

ARQ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARQ INC

NASDAQ:ARQ (9/26/2025, 8:00:00 PM)

After market: 7.16 0 (0%)

7.16

-0.24 (-3.24%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-05 2025-11-05
Inst Owners33.21%
Inst Owner ChangeN/A
Ins Owners18.57%
Ins Owner Change11.31%
Market Cap305.66M
Analysts82.22
Price Target10.91 (52.37%)
Short Float %4.91%
Short Ratio5.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.8%
Min EPS beat(2)-90.4%
Max EPS beat(2)100%
EPS beat(4)3
Avg EPS beat(4)30.69%
Min EPS beat(4)-90.4%
Max EPS beat(4)100%
EPS beat(8)5
Avg EPS beat(8)42.17%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.27%
Min Revenue beat(2)2.71%
Max Revenue beat(2)9.82%
Revenue beat(4)3
Avg Revenue beat(4)4.67%
Min Revenue beat(4)-7.12%
Max Revenue beat(4)13.26%
Revenue beat(8)6
Avg Revenue beat(8)6.6%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.9%
PT rev (3m)18.89%
EPS NQ rev (1m)-44.43%
EPS NQ rev (3m)-54.54%
EPS NY rev (1m)-118.18%
EPS NY rev (3m)-110.71%
Revenue NQ rev (1m)-3.12%
Revenue NQ rev (3m)-1.26%
Revenue NY rev (1m)-1.7%
Revenue NY rev (3m)2.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 27.44
P/S 2.6
P/FCF N/A
P/OCF 40.09
P/B 1.41
P/tB 1.46
EV/EBITDA 26.59
EPS(TTM)-0.01
EYN/A
EPS(NY)0.26
Fwd EY3.64%
FCF(TTM)-1.28
FCFYN/A
OCF(TTM)0.18
OCFY2.49%
SpS2.76
BVpS5.08
TBVpS4.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.58%
ROE -0.76%
ROCE 0.73%
ROIC 0.53%
ROICexc 0.55%
ROICexgc 0.56%
OM 1.47%
PM (TTM) N/A
GM 36.27%
FCFM N/A
ROA(3y)-3.97%
ROA(5y)1.37%
ROE(3y)-5.19%
ROE(5y)0.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.52%
GM growth 5Y4.26%
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA 2.35
Cap/Depr 629.02%
Cap/Sales 52.86%
Interest Coverage 250
Cash Conversion 65.64%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 0.65
Altman-Z 3.48
F-Score4
WACC9.1%
ROIC/WACC0.06
Cap/Depr(3y)475.88%
Cap/Depr(5y)322.19%
Cap/Sales(3y)39.34%
Cap/Sales(5y)27.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
EPS Next Y95.41%
EPS Next 2Y109.09%
EPS Next 3Y88.93%
EPS Next 5Y63.64%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y2.8%
Revenue growth 5Y9.22%
Sales Q2Q%12.51%
Revenue Next Year10.84%
Revenue Next 2Y16.73%
Revenue Next 3Y16.47%
Revenue Next 5Y17.79%
EBIT growth 1Y145.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year777.58%
EBIT Next 3Y180.36%
EBIT Next 5Y107.02%
FCF growth 1Y-16.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.31%
OCF growth 3Y-26.14%
OCF growth 5Y-29.98%